For people who've plateaued on tirzepatide or semaglutide, probably the most evidence-based subsequent stage in 2026 is optimizing the current protocol. Altering dose timing, revisiting macronutrient distribution, or incorporating resistance schooling to maintain lean mass through ongoing weight los